Welcome to our dedicated page for Gorman-Rupp Co SEC filings (Ticker: GRC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gorman-Rupp Company (NYSE: GRC) files reports with the U.S. Securities and Exchange Commission that provide detailed information on its pump and pumping equipment manufacturing business. This page brings together GRC’s SEC filings and pairs them with AI-generated summaries to help readers interpret the disclosures more efficiently.
Gorman-Rupp’s filings include Form 8-K current reports, such as those dated July 25, 2025 and October 24, 2025, which state that the company issued news releases announcing its financial results for the second and third quarters of 2025 and furnished those releases as exhibits. In addition to 8-Ks, investors can expect to find annual reports on Form 10-K, quarterly reports on Form 10-Q, and other required documents that describe net sales, gross margin, operating income, interest expense, net income, adjusted earnings measures, incoming orders, backlog, cash flows and risk factors.
For a manufacturer focused on pumps and pump systems, these filings are a primary source for understanding segment structure, geographic revenue mix, debt and refinancing activity, use of the LIFO inventory method, and the detailed risk disclosures the company provides under the Private Securities Litigation Reform Act safe harbor. They also document information related to dividends, capital expenditures and liquidity.
On this page, AI tools highlight key points from lengthy filings, explain terminology and draw attention to items such as non-GAAP reconciliations, debt terms and risk factor updates. Users can also review insider transaction reports on Form 4 and other ownership-related filings where available, to see how executives and other insiders are reporting their holdings under SEC rules.
Filings are updated as they are made available through the SEC’s EDGAR system, giving investors and researchers a structured view of Gorman-Rupp’s regulatory reporting over time, with summaries designed to make complex documents easier to navigate.
The Gorman-Rupp Company held its annual shareholder meeting virtually on April 23, 2026. Shareholders elected nine directors, with each nominee receiving roughly 19.5 million to 20.4 million votes in favor and relatively few votes withheld, indicating broad support.
Two additional shareholder proposals also passed with strong majorities, based on vote totals reported. After the meeting, the independent directors appointed Donald H. Bullock, Jr. as Lead Independent Director, succeeding M. Ann Harlan, who will continue serving on the Board.
The Gorman-Rupp Company reported solid first‑quarter 2026 growth, with net sales of $176.6 million, up 7.7% from 2025. Net income rose to $17.8 million, and earnings per share increased to $0.68 from $0.46, showing much stronger profitability.
Gross margin improved to 32.5% from 30.7%, helped by better labor and overhead leverage and a more profitable product mix. Operating income reached $27.5 million, while Adjusted EBITDA grew to $35.5 million. Backlog increased to $247.9 million, supported by broad-based demand across construction, agriculture, industrial, municipal and OEM markets.
The company generated $22.0 million of operating cash flow, funded $4.3 million of capital spending, paid $5.0 million in dividends and reduced bank debt by $15.0 million. Total debt stood at $295.8 million, and management expects a 2026 effective tax rate between 22.0% and 23.0%.
GORMAN RUPP CO director Donald H. Bullock received a stock grant. He acquired 1,344 shares of Common Stock as a grant or award at a stated price of $0.00 per share, increasing his direct holdings to 16,156 shares.
The 1,344 shares are restricted stock granted under the company’s shareholder-approved equity plan. According to the terms, this restricted stock will vest in full on the date immediately preceding the company’s next annual meeting of shareholders, aligning director compensation with shareholder interests over that period.
Heminger Pamela A reported acquisition or exercise transactions in this Form 4 filing.
GORMAN RUPP CO director Pamela A. Heminger received a grant of 1,344 shares of common stock as restricted stock compensation. The grant was made at no cash cost to her and came under the company’s shareholder-approved equity plan.
The restricted shares vest in full on the date immediately before the company’s next annual meeting of shareholders, meaning she must remain in service until then to receive them outright. After this award, Heminger directly holds a total of 4,915 common shares.
McClelland Sonja K reported acquisition or exercise transactions in this Form 4 filing.
GORMAN RUPP CO director Sonja K. McClelland received a grant of 1,344 shares of restricted common stock at $0.00 per share under the company’s shareholder-approved equity plan. The restricted stock will vest in full on the date immediately preceding the company’s next annual meeting of shareholders. Following this award, McClelland directly holds 15,826 shares of Gorman-Rupp common stock.
PETRELLA VINCENT K reported acquisition or exercise transactions in this Form 4 filing.
GORMAN RUPP CO director Vincent K. Petrella received a grant of 1,344 shares of common stock as restricted stock compensation. The award was granted at $0.00 per share under the company’s shareholder-approved equity plan and will vest in full on the date immediately preceding the company’s next annual meeting of shareholders.
Following this grant, Petrella directly holds 14,156 shares of GORMAN RUPP CO common stock. He also has an indirect holding of 2,700 shares through the Margaret A Petrella 2020 Irrevocable Trust, reflecting additional exposure via a related trust arrangement.
Reynolds Kenneth R reported acquisition or exercise transactions in this Form 4 filing.
GORMAN RUPP CO director Kenneth R. Reynolds received a grant of 1,344 shares of Common Stock. The shares were awarded at $0.00 per share as restricted stock under the company’s shareholder-approved equity plan.
Following this grant, Reynolds directly owns 35,406 Common Stock shares. According to the footnote, the restricted stock vests in full on the date immediately preceding the company’s next annual meeting of shareholders, meaning the shares become fully owned at that time if he remains eligible.
GORMAN RUPP CO director Christopher H. Lake received a grant of 1,344 shares of restricted common stock at $0.00 per share. The award was made under a shareholder-approved equity plan and will vest in full immediately before the company’s next annual meeting of shareholders.
Earlier in the month, Lake made a bona fide gift of 1,000 common shares. After these compensation and gift transactions, he directly holds 44,945 common shares.
Gorman-Rupp Co director Ann M. Harlan received a grant of 1,344 shares of restricted common stock at $0.00 per share as compensation. The restricted stock was granted under a shareholder-approved equity plan and will vest in full on the date immediately preceding the company’s next annual meeting of shareholders.
After this award and including 83 shares acquired through dividend reinvestment between January 1, 2026 and April 24, 2026, Harlan now directly owns 32,662 shares of Gorman-Rupp common stock.
The Gorman-Rupp Company delivered a strong first quarter of 2026 with higher sales, margins, earnings and cash flow. Net sales rose to $176.6 million, up 7.7% from the prior-year quarter, driven by higher volumes and pricing across most end markets, including construction, agriculture, industrial, municipal and OEM.
Gross margin improved to 32.5% from 30.7% and operating margin increased to 15.6% from 13.5%, reflecting better leverage on labor, overhead and SG&A plus favorable product mix. Net income reached a record $17.8 million, or $0.68 per share, compared with $12.1 million, or $0.46 per share. Adjusted EBITDA was $35.5 million, representing 20.1% of sales versus 18.1% a year earlier.
Incoming orders were $187.5 million, up 5.5%, and backlog increased to $247.9 million at March 31, 2026. Operating cash flow was $22.0 million, while capital spending was $4.3 million and total debt declined by $15.0 million in the first three months of 2026, supporting a stronger balance sheet.